Key result
High-power short-duration ablation linked to ~70% less acute pulmonary vein reconnection versus moderate power in AF.
Why the study?
While preliminary data suggested high-power short-duration (HPSD) ablation for pulmonary vein isolation is safe, limited data were available regarding its effectiveness.
Does high-power short-duration (HPSD) ablation improve procedural efficiency and pulmonary vein isolation rates compared to moderate power ablation in patients with atrial fibrillation?
Cohort (n=130)
Yes
Does high-power short-duration (HPSD) ablation improve procedural efficiency and pulmonary vein isolation rates compared to moderate power ablation in patients with atrial fibrillation?
Absolute Event Rate: 9.2% vs 30.8%
p-value: p=0.004
High-power short-duration ablation for atrial fibrillation is safe, significantly reduces procedure times, and lowers acute pulmonary vein reconnection rates compared to conventional moderate-power ablation.
HPSD ablation was associated with fewer acute reconnections; leaves open long-term durability and need for randomized confirmation.
INTRODUCTION: Preliminary data suggest that high power short duration (HPSD) ablation for pulmonary vein isolation (PVI) are safe. Limited data are available on its effectiveness. Aim was to evaluate HPSD ablation in atrial fibrillation ablation using a novel Qdot Micro catheter. METHODS AND RESULTS: Prospective multicenter study evaluating safety and efficacy of PVI with HPSD ablation. First pass isolation (FPI) and sustained PVI was assessed. If FPI was not achieved additional ablation index (AI)-guided ablation with 45 W was performed and metrics predictive of this were determined. Sixty-five patients and 260 veins were treated. Procedural and LA dwell time was 93.9 ± 30.4 and 60.5 ± 23.1 min, respectively. FPI was achieved in 47 (72.3%) patients and 231 veins (88.8%) with an ablation duration of 4.6 ± 1.0 min. Twenty-nine veins required additional AI-guided ablation to achieve initial PVI with 24 anatomical sites ablated with the right posterior carina being the most common site (37.5%). A contact force of ≥8 g (area under the curve [AUC]: 0.81; p < 0.001) and catheter position variation of ≤1.2 mm (AUC: 0.79; p < 0.001) with HPSD were strongly predictive of not requiring additional AI-guided ablation. Out of the 260 veins, only 5 (1.9%) veins showed acute reconnection. HPSD ablation was associated with shorter procedure times (93.9 vs. 159.4 min; p < 0.001), ablation times (6.1 vs. 27.7 min; p < 0.001), and lower rates of PV reconnection (9.2% vs. 30.8%; p = 0.004) compared to moderate power cohort. CONCLUSIONS: HPSD ablation is an effective ablation modality which results in effective PVI whilst maintaining a safety profile. Its superiority needs to be evaluated in randomized controlled trials.
No takes yet. Share an insight, caveat, or question.
Honarbakhsh et al. (2023) conducted a cohort in Atrial fibrillation (n=130). High-power short duration (HPSD) radiofrequency ablation vs. Moderate power (30-40W) ablation index-guided ablation was evaluated on Acute pulmonary vein reconnection (p=0.004). High-power short duration ablation significantly reduced acute pulmonary vein reconnection to 9.2% compared to 30.8% with moderate power ablation in patients with atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: